abrdn Healthcare Investors (N:HQH)

Sector:  Financials Industry:  Closed End Funds
 
See Regulatory Filings on SEC
Company Contact
Address: 1900 Market Street, Suite 200
PHILADELPHIA PA 19103
Tel: N/A
Website: https://www.abrdnhqh.com
IR: See website
<
Key People
Daniel R. Omstead
President, Trustee 		Laura Woodward
Chief Compliance Officer, Treasurer, Secretary 		 
Business Overview
abrdn Healthcare Investors (the Fund), formerly Tekla Healthcare Investors, is a non-diversified closed-end healthcare fund. The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. In addition, it seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets. It invests in healthcare industries and is focused on the smaller, emerging companies, investing a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. It invests in subsectors, such as biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare and others. abrdn Inc. is the investment adviser of the Fund.
Financial Overview
For the fiscal year ended 30 September 2023, abrdn Healthcare Investors revenues increased 24% to $10.3M. Net income totaled $56.3M vs. loss of $194.2M. Revenues reflect Dividend income increase of 10% to $8.8M, Interest and other income increase from $112K to $620K. Net Income reflects Investments in unaffiliated issuers decrease of 88% to $31.5M (expense), Investments in non affiliated issuers-Ne increase of 53% to $90.2M (income).
Reporting Currency: U.S. Dollars
Enterprise value: $805.05M as of Sep 30, 2023
Annual revenue (TTM): $10.29M as of Sep 30, 2023
EBITDA (TTM): -$1.19M as of Sep 30, 2023
Net annual income (TTM): $56.33M as of Sep 30, 2023
Free cash flow (TTM): N/A
Net Debt Last Fiscal Year: N/A
Shares outstanding: 49,442,016 as of Sep 30, 2023
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.

Learn More